Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Receivables - Doubtful (2016 - 2024)

Historic Receivables - Doubtful for HUTCHMED (China) (HCM) over the last 10 years, with Q4 2024 value amounting to $70000.0.

  • HUTCHMED (China)'s Receivables - Doubtful fell 5906.43% to $70000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $70000.0, marking a year-over-year decrease of 5906.43%. This contributed to the annual value of $70000.0 for FY2024, which is 5906.43% down from last year.
  • Per HUTCHMED (China)'s latest filing, its Receivables - Doubtful stood at $70000.0 for Q4 2024, which was down 5906.43% from $171000.0 recorded in Q4 2023.
  • HUTCHMED (China)'s Receivables - Doubtful's 5-year high stood at $171000.0 during Q4 2023, with a 5-year trough of $20000.0 in Q4 2021.
  • Over the past 5 years, HUTCHMED (China)'s median Receivables - Doubtful value was $70000.0 (recorded in 2024), while the average stood at $83200.0.
  • As far as peak fluctuations go, HUTCHMED (China)'s Receivables - Doubtful skyrocketed by 49375.0% in 2020, and later crashed by 7894.74% in 2021.
  • HUTCHMED (China)'s Receivables - Doubtful (Quarter) stood at $95000.0 in 2020, then crashed by 78.95% to $20000.0 in 2021, then surged by 200.0% to $60000.0 in 2022, then skyrocketed by 185.0% to $171000.0 in 2023, then tumbled by 59.06% to $70000.0 in 2024.
  • Its Receivables - Doubtful was $70000.0 in Q4 2024, compared to $171000.0 in Q4 2023 and $60000.0 in Q4 2022.